CVS Health Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
J. Joyner
Chief executive officer
US$17.8m
Total compensation
| CEO salary percentage | 6.20% |
| CEO tenure | 1yr |
| CEO ownership | 0.004% |
| Management average tenure | 2.7yrs |
| Board average tenure | 2.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2025 | n/a | n/a | US$5b |
| Mar 31 2025 | n/a | n/a | US$5b |
| Dec 31 2024 | US$18m | US$1m | US$5b |
Compensation vs Market: J.'s total compensation ($USD17.81M) is above average for companies of similar size in the CL market ($USD5.24M).
Compensation vs Earnings: Insufficient data to compare J.'s compensation with company performance.
CEO
J. Joyner (60 yo)
Mr. J. David Joyner is President, CEO & Director of CVS Health Corporation from October 17, 2024 and served as Executive Vice President from January 30, 2023 to October 17, 2024 and was President of CVS Ca...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 6.9yrs | US$305.00k | 0.00033% CLP 317.8m | |
| President | 1yr | US$17.81m | 0.0041% CLP 3.9b | |
| EVP of Ventures and Chief Experience & Technology Officer | 3.3yrs | US$11.36m | 0.0050% CLP 4.9b | |
| Executive VP & Chief People Officer | 1.1yrs | US$6.85m | no data | |
| Executive VP & Group President | 3.9yrs | US$13.27m | 0.0018% CLP 1.7b | |
| Executive VP & CFO | less than a year | no data | 0% CLP 0 | |
| Senior VP | 6.9yrs | no data | 0.00089% CLP 857.1m | |
| Executive VP & Chief Compliance Officer | no data | no data | no data | |
| Executive VP | 2.7yrs | US$11.89m | 0.0017% CLP 1.6b | |
| Head of Markets of Healthcare Benefits | 3.7yrs | no data | no data | |
| Chief Sustainability Officer & Senior VP of Corporate Social Responsibility | 2.7yrs | no data | no data | |
| President of Health Care Delivery & Executive VP | 3.4yrs | no data | 0.00088% CLP 847.5m |
Experienced Management: CVSCL's management team is considered experienced (2.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 6.9yrs | US$305.00k | 0.00033% CLP 317.8m | |
| President | 1yr | US$17.81m | 0.0041% CLP 3.9b | |
| Independent Director | 2yrs | US$335.00k | 0.00089% CLP 857.1m | |
| Independent Director | less than a year | US$167.50k | 0% CLP 0 | |
| Independent Director | 14.8yrs | US$335.00k | 0.0018% CLP 1.7b | |
| Independent Director | 18.6yrs | US$355.00k | 0.0099% CLP 9.6b | |
| Independent Director | 10.6yrs | US$335.00k | 0.00023% CLP 221.5m | |
| Independent Director | less than a year | US$167.50k | 0.00095% CLP 914.9m | |
| Independent Director | 6.9yrs | US$360.00k | 0.0031% CLP 3.0b | |
| Independent Director | 3.1yrs | US$348.33k | 0.00094% CLP 905.3m | |
| Director | less than a year | US$167.50k | 0.00034% CLP 327.4m | |
| Lead Independent Director | 1.9yrs | US$335.00k | 0.0036% CLP 3.5b |
Experienced Board: CVSCL's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/30 23:38 |
| End of Day Share Price | 2025/10/29 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CVS Health Corporation is covered by 49 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Harshit Gupta | Accountability Research Corporation |
| Christopher Graja | Argus Research Company |
| Hua Ha | Baird |